Impaired lung NK activity in the lung of Idiopathic Pulmonary Fibrosis patients
T. Cruz (Barcelona, Spain), A. Bondonese (Pittsburgh, United States of America), J. Sembrat (Pittsburgh, United States of America), T. Tabib (Pittsburgh, United States of America), W. Zhang (Pittsburgh, United States of America), N. Mitash (Pittsburgh, United States of America), D. Vignali (Pittsburgh, United States of America), A. Mora (Columbus, United States of America), R. Lafyatis (Pittsburgh, United States of America), M. Rojas (Columbus, United States of America)
Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Cruz (Barcelona, Spain), A. Bondonese (Pittsburgh, United States of America), J. Sembrat (Pittsburgh, United States of America), T. Tabib (Pittsburgh, United States of America), W. Zhang (Pittsburgh, United States of America), N. Mitash (Pittsburgh, United States of America), D. Vignali (Pittsburgh, United States of America), A. Mora (Columbus, United States of America), R. Lafyatis (Pittsburgh, United States of America), M. Rojas (Columbus, United States of America). Impaired lung NK activity in the lung of Idiopathic Pulmonary Fibrosis patients. 4332
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: